This project has received funding from the Innovative Medicines Initiative
On Thursday, December 4, the FACILITATE closing event Returning Individual Participant Data in Clinical Trials ‘by Design’. Setting a new standard for Patients’ Rights in Europe took place at the European Parliament in Brussels.The event was designed to...
The professional video summary of the event, produced by journalist Mariam Zaidi, distills the key messages, why RoIPD matters, and how the FACILITATE Principles turn ethics and law into day-to-day practice. Watch the interview...
On Thursday, December 4, the FACILITATE closing event Returning Individual Participant Data in Clinical Trials ‘by Design’. Setting a new standard for Patients’ Rights in Europe took place at the European Parliament in Brussels. The event was highly...
The FACILITATE White Paper on the return of individual participant data (RoIPD) in clinical trial is online! This relevant document turns “what if” into a practical roadmap, showing how “Why return individual data?” connects to real-world steps that make sharing back...
The FACILITATE project seeks to address the ethical and legal challenges surrounding the return of individual participant data (RoIPD) from clinical trials to participants aged 18 and older within the European Union (EU). Although there is growing recognition of the...
Return of Individual Participant Data (RoIPD) from clinical trials can empowerparticipants, improve health decision-making, and strengthen trust in research.However, RoIPD remains rare in the EU due to unclear responsibilities, limitedinfrastructure, and a lack of...
